BNTC vs. SPRO
BNTC (Benitec Biopharma Inc.) and SPRO (Spero Therapeutics, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, BNTC returned -29.92%/yr vs -31.31%/yr for SPRO. At a 0.12 correlation, their price movements are largely independent.
Performance
BNTC vs. SPRO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BNTC achieves a -8.69% return, which is significantly lower than SPRO's -5.15% return.
BNTC
- 1D
- 1.23%
- 1M
- 9.53%
- YTD
- -8.69%
- 6M
- -0.40%
- 1Y
- -15.81%
- 3Y*
- 53.77%
- 5Y*
- -29.92%
- 10Y*
- -28.11%
SPRO
- 1D
- -3.07%
- 1M
- -19.93%
- YTD
- -5.15%
- 6M
- -6.75%
- 1Y
- -26.82%
- 3Y*
- 11.37%
- 5Y*
- -31.31%
- 10Y*
- —
BNTC vs. SPRO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BNTC Benitec Biopharma Inc. | -8.69% | 6.65% | 291.02% | 11.76% | -93.51% | -12.67% | -60.78% | -66.00% | -49.27% | 4.70% |
SPRO Spero Therapeutics, Inc. | -5.15% | 126.21% | -29.93% | -15.03% | -89.19% | -17.43% | 101.66% | 56.34% | -47.66% | -11.32% |
Correlation
The correlation between BNTC and SPRO is 0.24, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.24 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.13 |
Correlation (All Time) Calculated using the full available price history since Nov 2, 2017 | 0.12 |
The correlation between BNTC and SPRO shifts across timeframes, from 0.12 (all time) to 0.24 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
BNTC:
$607.45M
SPRO:
$126.59M
BNTC:
-$1.13
SPRO:
$0.39
BNTC:
957.27
SPRO:
2.31
BNTC:
3.31
SPRO:
2.39
BNTC:
$556.00K
SPRO:
$54.77M
BNTC:
$40.00K
SPRO:
$54.51M
BNTC:
-$55.66M
SPRO:
$12.49M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BNTC vs. SPRO — Risk / Return Rank
BNTC
SPRO
BNTC vs. SPRO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Benitec Biopharma Inc. (BNTC) and Spero Therapeutics, Inc. (SPRO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BNTC | SPRO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.20 | ||
| Sortino ratioReturn per unit of downside risk | +0.34 | ||
| Omega ratioGain probability vs. loss probability | 1.01 | 0.96 | +0.05 |
| Calmar ratioReturn relative to maximum drawdown | -0.41 | -0.68 | +0.27 |
| Martin ratioReturn relative to average drawdown | -0.67 | -1.16 | +0.50 |
Loading charts...
Drawdowns
BNTC vs. SPRO - Drawdown Comparison
The maximum BNTC drawdown since its inception was -99.92%, roughly equal to the maximum SPRO drawdown of -97.46%. Use the drawdown chart below to compare losses from any high point for BNTC and SPRO.
Loading charts...
Drawdown Indicators
| BNTC | SPRO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.92% | -97.46% | -2.46% |
Max Drawdown (1Y)Largest decline over 1 year | -39.10% | -39.80% | +0.70% |
Max Drawdown (3Y)Largest decline over 3 years | -68.46% | -68.89% | +0.43% |
Max Drawdown (5Y)Largest decline over 5 years | -97.41% | -97.13% | -0.28% |
Max Drawdown (10Y)Largest decline over 10 years | -99.82% | — | — |
Current DrawdownCurrent decline from peak | -99.46% | -89.99% | -9.47% |
Average DrawdownAverage peak-to-trough decline | -88.42% | -62.42% | -26.00% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 23.80% | 23.07% | +0.73% |
Volatility
BNTC vs. SPRO - Volatility Comparison
The current volatility for Benitec Biopharma Inc. (BNTC) is 15.84%, while Spero Therapeutics, Inc. (SPRO) has a volatility of 33.20%. This indicates that BNTC experiences smaller price fluctuations and is considered to be less risky than SPRO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BNTC | SPRO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.84% | 33.20% | -17.36% |
Volatility (6M)Calculated over the trailing 6-month period | 38.29% | 45.15% | -6.86% |
Volatility (1Y)Calculated over the trailing 1-year period | 60.76% | 58.66% | +2.10% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 101.68% | 152.13% | -50.45% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 132.09% | 124.91% | +7.18% |
Dividends
BNTC vs. SPRO - Dividend Comparison
Neither BNTC nor SPRO has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
BNTC Benitec Biopharma Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.20% |
SPRO Spero Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
BNTC vs. SPRO - Financials Comparison
This section allows you to compare key financial metrics between Benitec Biopharma Inc. and Spero Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
BNTC and SPRO have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SPRO has higher volatility (33.20%) compared to BNTC (15.84%). In terms of maximum drawdown, BNTC dropped -99.92% vs SPRO's -97.46%.
BNTC currently has the higher Sharpe Ratio (-0.26 vs -0.46), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BNTC and SPRO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer